Table 1.

Enrollment criteria for the MAGIC Cell-5-Combination Cytokine Trial.

Inclusion criteria
Age: 18 to 80 years
Able to verbally confirm understandings of risks, benefits, and treatment alternatives of receiving the cell therapy provides written informed consent before any study-related procedure
ST-segment elevation acute myocardial infarction
Successful revascularization of culprit vessel
Exclusion criteria
Known hypersensitivity or contraindication to any of the following medications:
Heparin, aspirin, clopidogrel, sirolimus, everolimus, contrast media
Uncontrolled congestive heart failure (patients with LVEF <20% or Killip class II, III or those with cardiogenic shock)
Uncontrolled myocardial ischemia (repeated chest pain or dyspnea after revascularization)
Uncontrolled ventricular arrhythmia
History of malignancy
Serious hematologic disease
Current infectious disease needs antibiotics therapy
Creatinine level >2.0 mg/dL or dependence on dialysis

LVEF, left ventricular ejection fraction